DENTSPLY SIRONA (NASDAQ:XRAY) Earns Outperform Rating from Barrington Research

Barrington Research reissued their outperform rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report issued on Friday morning, Benzinga reports. The brokerage currently has a $36.00 target price on the medical instruments supplier’s stock.

Other analysts also recently issued reports about the stock. Needham & Company LLC reissued a buy rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating for the company in a report on Monday, July 22nd. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating for the company in a report on Thursday, July 18th. Finally, Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating for the company in a report on Tuesday, July 9th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of $33.22.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $26.29 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. DENTSPLY SIRONA has a fifty-two week low of $23.58 and a fifty-two week high of $37.60. The firm has a fifty day moving average price of $25.56 and a two-hundred day moving average price of $27.82. The company has a market cap of $5.46 billion, a PE ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. During the same period last year, the company earned $0.51 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% on a year-over-year basis. Analysts expect that DENTSPLY SIRONA will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Principal Securities Inc. acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at about $26,000. LRI Investments LLC grew its position in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $64,000. Finally, Mather Group LLC. bought a new position in DENTSPLY SIRONA during the 1st quarter worth approximately $72,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.